首页> 外文期刊>BMC Urology >Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study
【24h】

Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study

机译:接受幽门螺杆菌根除治疗幽门螺杆菌患者的消化性溃疡患者随后的前列腺癌风险:基于亚洲人口的群组研究

获取原文
           

摘要

Studies have shown diverse results regarding the association between H. pylori (HP) infection and the risk of malignancy. There is accumulating evidence relating HP infection to urological diseases. We investigated whether there was an association between HP-infected peptic ulcers and the subsequent risk of prostate cancer. We collected HP-infected male patients from 1998 to 2008 from the Longitudinal Health Insurance Database (LHID). HP-infected patients were identified as those who had a diagnosis of peptic ulcers upon admission and received HP eradication therapy within 1 year after diagnosis. The date of HP infection diagnosis upon admission was defined as the index date. Patients aged ?20?years or with a cancer history were excluded. For each HP-infected patient, we selected four males without peptic ulcers or a history of HP eradication in the LHID for the comparison cohort according to propensity score matching by age, index year, and comorbidity. The risk of prostate cancer and associated risk factors was assessed by Cox proportional hazard regression. A total of 2620 HP infection treatment patients and 10,480 matched comparisons were selected. There were 36 patients in the HP-infected treatment cohort and 117 patients in the comparison cohort with documented prostate cancer development (1.52 and 1.21 per 1000 person-years, respectively). Compared to the comparison cohort, the HP infection cohort had a 1.26-fold increased prostate cancer risk in the Cox models after adjusting for matched-pairs (95% CI?=?0.87–1.34). There were no significant differences in subsequent prostate cancer development between HP-infected treatment patients and the comparison cohort. Our findings showed no significant association between HP-infected peptic ulcers and the subsequent risk of prostate cancer. Further studies are warranted to investigate whether this observation is attributable to an HP eradication policy.
机译:研究表明了关于幽门螺杆菌(HP)感染与恶性肿瘤风险的关联的多样化结果。有与HP感染泌尿外科疾病越来越多的证据。我们调查是否有HP感染的消化性溃疡和前列腺癌的风险以后之间的关联。我们收集了从纵向健康保险数据库(LHID)HP感染的男性患者1998年至2008年。 HP感染的患者被鉴定为在诊断后1年内诊断和接受HP根除治疗后诊断消化溃疡的患者。入院时HP感染诊断的日期定义为指数日期。患者<20?岁月或癌症史被排除在外。对于每个HP感染的患者,我们选择了四个男性无消化性溃疡或根除HP在LHID根据年龄倾向评分匹配,指数一年,合并症比较队列的历史。前列腺癌和相关的风险因素的风险是由Cox比例风险回归评估。共有2620周HP感染治疗的患者和10480个匹配的比较选择。 HP感染治疗队列中有36名患者,比较队列的117名患者,记录了前列腺癌症发展(分别为每1000人的1.52和1.21岁)。与比较队列相比,HP感染队列在调整匹配对后的COX模型中的前列腺癌风险增加1.26倍(95%CI?= 0.87-1.34)。有在随后的前列腺癌发展的HP感染治疗的患者和对照组群之间没有显著差异。我们的研究结果显示,HP感染的消化性溃疡和前列腺癌的风险以后之间没有显著关联。进一步的研究来调查这一观察是归因于HP根除政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号